SDC1 and Kawasaki disease: It has been shown that in the acute phase of Kawasaki disease, circulating levels of VEGLX (syndecan-1 and hyaluronic acid) are significantly elevated, and serum hyaluronic acid is the most useful prognostic biomarker for predicting future onset or exacerbation of coronary artery lesions in Kawasaki disease [46].